Author

L. Kind

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Assay:protein structure· 2 Approach:biophysical modeling· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

T. Arnesen· 3 shared A. Raasakka· 2 shared P. Kursula· 2 shared P. R. Njolstad· 2 shared A. Drazic· 1 shared A. Kaziales· 1 shared I. Aukrust· 1 shared J. Molnes· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

T. Arnesen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Structural properties of the HNF-1A transactivation domain

L. Kind, M. Driver, A. Raasakka, P. R. Onck, P. R. Njolstad, T. Arnesen, P. Kursula

The paper characterizes the disordered structure and functional properties of the HNF-1A transactivation domain using bioinformatics and biophysical methods.

bioRxiv · Jun 23, 2023Biochemistry

Structural and biophysical characterization of HNF-1A as a tool to study MODY3 diabetes variants

L. Kind, A. Raasakka, J. Molnes, I. Aukrust, L. Bjorkhaug, P. R. Njolstad, P. Kursula, T. Arnesen

This study structurally and biophysically characterizes HNF-1A variants associated with MODY3 diabetes, showing reduced functionality in three variants compared to wild-type.

bioRxiv · Dec 20, 2021 · PreprintBiochemistry

PFN2 and NAA80 cooperate to efficiently acetylate the N-terminus of actin

R. Ree, L. Kind, A. Kaziales, S. Varland, M. Dai, K. Richter, A. Drazic, T. Arnesen

The paper identifies PFN2 as a specific regulator of NAA80, enhancing its catalytic activity and promoting actin N-terminal acetylation.

bioRxiv · Jul 15, 2020Biochemistry